COVID-19 and IP Waiver for Patent Protection

Recently, the U.S.’s changed position on IP Waiver for patent protection of the COVID-19 vaccines and technology grabbed the headlines. It was an about face from its previous stance. But what does it all mean? From Facebook posts to conversations at the pickup line, it seems people don’t really understand what this IP Waiver means at all. In this video, NGE IP partners Olivia Luk Bedi and Kevin O'Connor explain what this news is all about.